2,5-disubstituted pyrimidine derivatives

US7091198B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Achim Feurer · Wilhelmsfeld, DE
• Joachim Luithle · Wülfrath, DE
• Stephan-Nicholas Wirtz · Wuppertal, DE
• Gerhard Konig · Düsseldorf, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Elke Stahl · Bensberg, DE
• Rudy Schreiber · Menlo Park, US
• Frank Wunder · Wuppertal, DE

Key dates

• Filing date: Jul 7, 2003
• Grant date: Aug 15, 2006
• Expiry date: Jul 7, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel 2,5-disubstituted pyrimidine derivatives which stimulate soluble guanylate cyclase, to processes for the preparation thereof, and to the use thereof for producing medicaments, in particular medicaments for the treatment of central nervous system diseases.